News

Abilify (aripiprazole) Oral Solution will provide an important new option for adult patients who are unable to swallow or have difficulty swallowing tablets, providing a greater measure of

According to terms of the agreement, NeoPharm received an initial up-front license fee of $2 million. Nippon Kayaku is responsible for all development costs in Japan. NeoPharm will

Simultaneous with the initiation of this collaboration, Enterprise Partners and Venrock Associates, venture capital funds that have invested in Celladon, made a $6 million common stock investment in

In the areas of cancer, dermatology and cardiovascular disease, Vitae has four lead product candidates poised for clinical development in 2005, as well as a pipeline of additional

The PLACQUE (progression limitation in Alzheimer’s: clioquinol’s efficacy) trial will be conducted over 52 weeks and will enroll 435 patients in the UK, Australia and the Republic of

Based on this agreement, Solvay has withdrawn its previously announced notice of termination. The topically applied Pennsaid lotion has been proven to offer effective relief of pain and

Respiratory syncytial virus (RSV) infects nearly every child by the age of two years and typically results in cold-like symptoms; however, it may lead to lower respiratory tract

Under the terms of the agreement, Ventiv Pharma Services will provide Bristol-Myers Squibb with a professional sales representative team, the entire field and internal management staff, full operational

Under the terms of the agreement, Cell Therapeutics Inc (CTI) will receive license fees, together with milestone payments on the achievement of predetermined development goals, royalties on sales